1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a broad range of fields, including medicine, biology, geology, and agriculture.

With the advancement of DNA sequencing technology and dramatic decline in sequencing costs, DNA sequencing is increasingly showing its market potential in noninvasive detection, disease diagnosis, and personalized treatment. In 2013, the market size of global DNA sequencing (including equipment and consumables, service and workflow, etc.) approximated USD4.6 billion, up around 26% from the previous year. It is projected that by 2017 this figure will reach USD10.096 billion, exceeding USD10 billion for the first time.

Ever since 1975, DNA sequencing technology has been through four generations, but the fourth-generation technology—Nanopore sequencing is still under development. Due to technologies and costs, the second-generation high-throughput sequencers are the mainstream sequencing platform around the world, with its total number occupying over 95% of next-generation DNA sequencers worldwide.

The upstream sectors of DNA sequencing industry are extremely robust, with the global market dominated by the second-generation DNA sequencing enterprises including Illumina, Thermo Fisher Scientific (through Life Technologies), Roche and the third-generation sequencing enterprises such as Pacific Biosciences. A review of these giants’ development history shows that mergers and acquisitions are the main driving forces behind the great market power. In February 2014, Roche acquired Life Technologies for USD13.6 billion, making it the industry giant second only to Illumina.

In China, the upstream sectors of DNA sequencing industry are virtually monopolized by foreign giants. BGI is the leader in China’s DNA sequencing service, and its second-generation DNA sequencers top the global chart in number. However, two of its sequencers—HiSeq 2000 and Ion Proton were entirely from Illumina and Life Technologies. In March 2013, BGI acquired Complete Genomics, a sign that BGI formally ventured into the upstream sectors of DNA sequencing industry. In June 2014, BGI’s two products—BGISEQ-1000 and BGISEQ-100 became the first second-generation DNA sequencers registered in China.

It is expected, however, that within the next five years the weak position of Chinese enterprises in upstream sectors will remain unchanged except for the epic M&A.

Global and China DNA Sequencing Industry Research Report, 2014-2017 mainly focuses on the followings:

Features, cost, etc. of DNA sequencing technology;
Major M&As, genetic database, market size and structure, etc. of global DNA sequencing industry;
Development, industry policies, market structure and prospects, etc. of DNA sequencing industry in China;
Operation, DNA sequencing business, etc. of 12 enterprises at home and abroad.

Table Of Contents

Global and China DNA Sequencing Industry Research Report, 2014-2017
1. Overview of DNA Sequencing Industry
1.1 Definition
1.2 Industry Chain
1.3 Application
1.4 Development History and Technical Features
1.5 Cost

2. Global DNA Sequencing Industry
2.1 Industry Chain Layout of Major Enterprises
2.2 Major MandAs
2.3 Genetic Database
2.4 Sequencer
2.5 Market Size and Prospects

3. China DNA Sequencing Industry
3.1 Development
3.2 Policy Environment
3.3 Market Structure
3.3.1 Sequencer
3.3.2 Service
3.4 Prospects

4. Key Enterprises
4.1 Illumina
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 RandD and Investment
4.1.6 DNA Sequencing
4.1.7 Development Prospects
4.2 Thermo Fisher Scientific
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Operating Margin
4.2.5 RandD and Investment
4.2.6 DNA Sequencing
4.2.7 Development in China
4.2.8 Development Prospects
4.3 BGI
4.3.1 Profile
4.3.2 Operation
4.3.3 DNA Sequencing
4.4 Roche
4.4.1 Profile
4.4.2 DNA Sequencing
4.5 Qiagen
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 RandD
4.5.5 DNA Sequencing
4.6 Pacific Biosciences
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 RandD
4.6.5 DNA Sequencing
4.7 Sequenom
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Operating Margin
4.7.5 RandD
4.7.6 DNA Sequencing
4.8 DAAN Gene
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 RandD
4.8.6 DNA Sequencing
4.8.7 Development Prospects
4.9 Agilent Technologies
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 RandD
4.9.5 DNA Sequencing
4.10 Berry Genomics
4.10.1 Profile
4.10.2 DNA Sequencing
4.11 Hunan China Sun Pharmaceutical Machinery
4.11.1 Profile
4.11.2 DNA Sequencing
4.12 Jilin Zixin Pharmaceutical Industrial
4.12.1 Profile
4.12.2 Operation
4.12.3 DNA Sequencing

Companies Mentioned

Illumina
Thermo Fisher Scientific
BGI
Roche
Qiagen
Pacific Biosciences
Sequenom
DAAN Gene
Agilent Technologies
Berry Genomics
Hunan China Sun Pharmaceutical Machinery
Jilin Zixin Pharmaceutical Industrial

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global DNA Sequencing Market Forecast 2017-2023

Global DNA Sequencing Market Forecast 2017-2023

  • $ 3950
  • Industry report
  • December 2016
  • by Inkwood Research

Key Findings The global DNA sequencing market is poised to grow during the forecast period of 2017-2023. Various reasons for growth of the DNA sequencing market are increase in demand for noninvasive detection, ...

Asia Pacific DNA Sequencing Market Forecast 2017-2023

Asia Pacific DNA Sequencing Market Forecast 2017-2023

  • $ 2038
  • Industry report
  • January 2017
  • by Inkwood Research

KEY FINDINGS Asia-Pacific market is expected to report good growth in the forecast period due to higher awareness and demand for personalized medicine. Factors, which favor growth of DNA sequencing market, ...

North America DNA Sequencing Market Forecast 2017-2023

North America DNA Sequencing Market Forecast 2017-2023

  • $ 2038
  • Industry report
  • January 2017
  • by Inkwood Research

KEY FINDINGS North America has the largest market share of the DNA sequencing market. Factors, which favor growth of DNA sequencing market, are better healthcare infrastructure, awareness about latest ...


Download Unlimited Documents from Trusted Public Sources

Genome Sequencing Industry in the US

  • February 2017
    93 pages
  • Genome Sequenci...  

    Crop Production  

  • United States  

View report >

Biological Therapy Industry in the US and Africa

  • February 2017
    6 pages
  • Biological Ther...  

    Biotechnology  

    Genomics  

  • United States  

    Africa  

View report >

Biological Therapy Industry in the US

  • February 2017
    12 pages
  • Biological Ther...  

    Biotechnology  

    Genomics  

  • United States  

View report >

Genomics Industry

17 days ago

Genomics Industry

1 month ago

Cytogenetic Statistics

2 months ago

Related Market Segments :

DNA Sequencing
Genome Sequencing

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.